News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Janssen Biotech Inc. Release: New Data Demonstrate STELARA® (Ustekinumab) is Effective and Improves Quality of Life in Patients With Moderate to Severe Plaque Psoriasis


10/3/2012 10:17:12 AM

HIGH WYCOMBE, UK--(BUSINESS WIRE)--A series of data presentations released at the 21st European Academy of Dermatology and Venereology (EADV) congress, in Prague, Czech Republic, demonstrate that STELARA® (ustekinumab) is effective, generally well-tolerated and improves quality of life in patients with moderate-to-severe plaque psoriasis.

Read at BioSpace.com


comments powered by Disqus
   
Psoriasis

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES